Endonovo Therapeutics, Inc.
ENDV· OTC
ENDVEndonovo Therapeutics, Inc.
Filed May 20, 2013 · 10-Q · 50 days after period end · 0001469709-13-000345
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $0.00 | $1.67K | $0.00 |
| Net Income | -$1.13M | -$430.78K | $0.00 |
| EPS Diluted | -$0.02 | -$0.01 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endonovo Therapeutics, Inc. · CIK 1528172 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 20, 2013 · 50 d after period end
